During the past decade, Mississippi Center for Advanced Medicine conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mississippi Center for Advanced Medicine" #1 sponsor was "Pfizer" with 5 trials, followed by "Spark Therapeutics" with 4 trials sponsored, "American Thrombosis and Hemostasis Network" with 2 trials sponsored, "Agios Pharmaceuticals, Inc." with 1 trials sponsored and "BioMarin Pharmaceutical" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mississippi Center for Advanced Medicine" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hemophilia of Georgia, Inc." with 1 trials as a collaborator, "LFB USA, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Mississippi Center for Advanced Medicine" are "Hemophilia A" (6 trials), "Hemophilia B" (5 trials), "Blood Coagulation Disorder" (2 trials), "Blood Coagulation Disorders, Inherited" (2 trials) and "Coagulation Protein Disorders" (2 trials). Many other conditions were trialed in "Mississippi Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "Mississippi Center for Advanced Medicine" are "Drug" (6 trials), "Biological" (4 trials), "Genetic" (4 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "SPK-8011" (2 trials), "Standard of Care FVIII Replacement therapy" (2 trials), "Advate (High Dose)" (1 trials), "Advate (Low Dose)" (1 trials) and "BIVV001 (High Dose)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mississippi Center for Advanced Medicine" are 10 trials for "Male" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Mississippi Center for Advanced Medicine". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Mississippi Center for Advanced Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mississippi Center for Advanced Medicine, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".